Shanghai MicroPort Endovascular MedTech Co., Ltd. (688016.SS)
- Previous Close
86.64 - Open
86.64 - Bid 86.42 x --
- Ask 86.43 x --
- Day's Range
86.30 - 87.60 - 52 Week Range
78.62 - 135.58 - Volume
867,617 - Avg. Volume
1,906,198 - Market Cap (intraday)
10.654B - Beta (5Y Monthly) 0.25
- PE Ratio (TTM)
23.88 - EPS (TTM)
3.62 - Earnings Date --
- Forward Dividend & Yield 4.66 (5.39%)
- Ex-Dividend Date Nov 8, 2024
- 1y Target Est
--
Shanghai MicroPort Endovascular MedTech Co., Ltd. engages in the research and development, manufacturing, and sale of aortic and peripheral vascular medical devices in China and internationally. The company's products include branched aortic stent graft system, thoracic stent graft system, abdominal aortic stent graft and delivery system, bifurcated stent graft system, and other stent graft system in surgical operation, as well as accessories, such as balloon inflation catheter. Shanghai MicroPort Endovascular MedTech Co., Ltd. was incorporated in 2012 and is based in Shanghai, the People's Republic of China.
www.endovastec.comRecent News: 688016.SS
View MorePerformance Overview: 688016.SS
Trailing total returns as of 5/23/2025, which may include dividends or other distributions. Benchmark is SSE Composite Index (000001.SS) .
YTD Return
1-Year Return
3-Year Return
5-Year Return
Compare To: 688016.SS
Select to analyze similar companies using key performance metrics; select up to 4 stocks.
Statistics: 688016.SS
View MoreValuation Measures
Market Cap
10.65B
Enterprise Value
8.67B
Trailing P/E
23.88
Forward P/E
--
PEG Ratio (5yr expected)
--
Price/Sales (ttm)
9.04
Price/Book (mrq)
2.77
Enterprise Value/Revenue
7.34
Enterprise Value/EBITDA
14.73
Financial Highlights
Profitability and Income Statement
Profit Margin
37.90%
Return on Assets (ttm)
6.29%
Return on Equity (ttm)
10.99%
Revenue (ttm)
1.18B
Net Income Avi to Common (ttm)
447.44M
Diluted EPS (ttm)
3.62
Balance Sheet and Cash Flow
Total Cash (mrq)
2.15B
Total Debt/Equity (mrq)
4.14%
Levered Free Cash Flow (ttm)
-244.92M